09:43 AM EDT, 05/15/2026 (MT Newswires) -- Sana Biotechnology ( SANA ) sold 21.6 million shares through its at-the-market equity program, raising $69 million in net proceeds, the company said Friday.

The proceeds, combined with a previously disclosed $25 million investment from the Mayo Clinic, bring the company's total capital raised since the end of Q1 to $94 million, extending its cash runway into mid-2027, the company added.

Shares of Sana Biotechnology ( SANA ) were down more than 5% in recent Friday trading.

Price: 2.99, Change: -0.16, Percent Change: -4.94